WeVote
Log In

Bill

Bill

HRES 1331

Expressing support for the designation of June 1, 2026, through June 7, 2026, as "Hidradenitis Suppurativa Awareness Week".

119th Congress Introduced by Debbie Dingell and 1 co-sponsor

The bill designates June 1–7, 2026 as Hidradenitis Suppurativa Awareness Week to boost awareness, education, early diagnosis, and access to care and research.

Submitted in House
0
WeVote Research Nonpartisan
Bill Summary · HRES 1331

Overview

  • Bill: HRES 1331
  • Session: 119th Congress, 2nd Session
  • Type: House Resolution
  • Purpose: Express support for designating June 1–7, 2026, as Hidradenitis Suppurativa Awareness Week.

Main Purpose and Intent

  • The resolution expresses support for recognizing a dedicated awareness week to highlight Hidradenitis Suppurativa (HS).
  • It aims to raise public awareness, strengthen education for the public and health professionals, and catalyze progress in diagnosis, treatment, and care for HS patients.

Key Provisions

  • Gratitude and Support:
    • The House supports designating June 1–7, 2026, as “Hidradenitis Suppurativa Awareness Week.”
  • Recognitions and Goals:
    • Emphasizes the importance of increasing awareness and education about HS among the public and health professionals.
    • Promotes timely and accurate diagnosis through improved screening and culturally competent care.
    • Endorses ongoing biomedical research to better understand HS pathogenesis, treatment efficacy, and long-term outcomes.
    • Supports the development of effective treatments and expansion of access to existing therapies.
    • Advocates for policies that improve access to care and quality of life for people living with HS and their caregivers.

Who/What Would Be Affected

  • Affected Population:
    • People living with Hidradenitis Suppurativa in the United States (estimated around 3.3 million).
  • Stakeholders Benefited:
    • Patients and caregivers, healthcare professionals, researchers, and health policy advocates.
  • No new mandates or funding are specified in the text of the resolution; it primarily states support and recognizes objectives.

Procedural and Timeline Aspects

  • Introduction and Sponsorship:
    • Introduced by Rep. Debbie Dingell (D-MI) with Rep. John Joyce (R-PA) as a co-sponsor.
  • Referral:
    • Referred to the House Committee on Energy and Commerce.
  • Action History:
    • Submitted on June 2, 2026; later referred to the committee the same day.
  • Effective Period:
    • The resolution designates a one-week period in 2026 (June 1–7) for awareness activities.

Potential Impact

  • Public Awareness: Increased visibility of HS, its impact, and the importance of early diagnosis and comprehensive care.
  • Education and Training: Encourages education of health professionals and the public about HS signs, diagnosis, and management.
  • Research and Policy: Signals congressional support for HS research and policies that could improve access to care and treatments in the future.
  • No direct fiscal appropriations or regulatory changes are specified in the resolution itself; any impact would depend on subsequent legislation or agency actions that align with the awareness week designation.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.